Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An efficient control strategy for dosage regimens

C Hu1, W S Lovejoy, S L Shafer

  • 1Stanford University School of Medicine, Anesthesiology Service (112A), Palo Alto, California.

Journal of Pharmacokinetics and Biopharmaceutics
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertension and myocardial fibrosis: A systematic review and meta-analysis.

Clinical radiology·2026
Same author

Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2026
Same author

Observation of Charmonium Sequential Suppression in Heavy-Ion Collisions at the Relativistic Heavy Ion Collider.

Physical review letters·2026
Same author

[Analysis of novel mutations in the SLC12A3 gene of a family with Gitelman syndrome].

Zhonghua nei ke za zhi·2026
Same author

Multi-omics reveals associations between feed efficiency, physiological traits and meat quality in slow-growing chickens.

British poultry science·2026
Same author

Prognostic score models for acquired resistance to frontline anti-programmed cell death protein 1/programmed death-ligand 1 therapy in metastatic non-small-cell lung cancer.

ESMO real world data and digital oncology·2026
Same journal

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Pharmacokinetics of methotrexate in solid tumors.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Journal of pharmacokinetics and biopharmaceutics·2010
See all related articles

Efficient drug dosage strategies are crucial for maintaining therapeutic drug concentrations. A new VU control strategy demonstrates superior performance and robustness compared to the maximum a posteriori (MAP) Bayesian method in simulations.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Mathematical Modeling in Medicine
  • Bayesian Statistics in Clinical Therapy

Background:

  • Maintaining optimal drug concentrations is essential for effective medical drug therapy.
  • Compartment models are frequently used to describe drug concentration-dosage relationships, but model parameters are often unknown.
  • Maximum a posteriori (MAP) Bayesian control is the current standard for adaptive drug dosing.

Purpose of the Study:

  • To evaluate the performance and robustness of the MAP Bayesian control strategy.
  • To propose and assess an alternative control strategy for optimizing drug dosage regimens.

Main Methods:

  • Simulations were conducted within a one-compartment pharmacokinetic model.
  • The performance of the MAP Bayesian strategy was analyzed based on prior distribution assumptions and cost functions.

Related Experiment Videos

  • A novel VU control strategy was developed and compared against the MAP Bayesian approach.

    • Main Results:

    • The performance of the MAP Bayesian strategy is sensitive to prior distribution assumptions and the chosen cost function.
    • The proposed VU control strategy consistently outperformed the MAP Bayesian strategy in various simulated scenarios.
    • The VU strategy exhibited greater robustness compared to the MAP Bayesian method.

    Conclusions:

    • The MAP Bayesian control strategy's efficacy is contingent on accurate prior knowledge and appropriate cost function selection.
    • The VU control strategy offers a more reliable and robust alternative for optimizing drug dosage regimens in medical therapy.
    • This study highlights the potential of the VU strategy to improve patient outcomes through enhanced drug concentration management.